CNMD conmed.com Profit After Tax

Corporate emblem and logo of conmed.com (CNMD)

By leveraging effective collaboration with external electronics manufacturers, CONMED Corporation (CNMD) flexibly scales production, as confirmed by the market dynamics reflected in the quotes on GURU.Markets, where the indicator stands at 0.07. The company creates a closed ecosystem of endoscopic systems, retaining customers through high-cost replaceable components. Revenue is generated through wholesale supplies of instruments and high-tech equipment to clinics and orthopedic centers worldwide.

Net Income: CONMED Corp. (CNMD) for 07/04/2022 - 11/01/2026

Financial and market metric breakdowns for CONMED (CNMD)

- market value and analyst target forecast:
Stock Price CONMED Inc.|CNMD - Price Target Chart
- market capitalization data:
Market Valuation CONMED Inc.|CNMD - Enterprise Value
- issuer book value statistics:
Net Asset Value per Share CONMED|CNMD - Company Net Assets|Market Capitalization to Book Value Ratio conmed.com|CNMD - Cumulative Company Assets
- debt burden and liquidity indicators:
Aggregate Debt to Capital CONMED Corporation|CNMD - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient CONMED Corp|CNMD - Company Aggregate Debts|Debt to Book Value CONMED Inc.|CNMD - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings CONMED|Quick Liquidity Indicator conmed.com
- company profitability and valuation multiples indicators:
CNMD - Net Profit
Fundamental valuation:CNMD, CONMED Inc.
Flagship merchandise of CONMED Corp.

CONMED Corporation (CNMD) profit represents the final financial result after deducting all operating and tax expenses. By analyzing the net income dynamics of CONMED Corporation (CNMD), investors assess the efficiency of capital management. This metric is extremely sensitive to Fed rate changes, which is immediately reflected in borrowing costs. The stability of this curve is supported by demand for electrosurgical equipment and imaging systems. The current trend confirms the business's resilience to logistical disruptions.

Key competitors

Dexcom CGM (DXCM) - Net Profit|Company Net Income Penumbra, Inc.|novanta.com - Profit After Tax|Net Profit HAE|INSP - Company Net Income|PROCEPT BioRobotics Inc - Net Income|Net Profit Pulse Medical PLSE|INMD: Net Income|picardmedical.com - Profit After Payment of Taxes|SRDX: Net Profit|SENS - Net Financial Result|NPCE (NeuroPace Corp) - Net Profit|Net Income Tactile Systems Technology Inc. (TCMD)|Net Income SNWV (Sanuwave Health Inc)|OM (outsetmedical.com) - Final Profit|Company Net Income Electromed ELMD|LNSR - Net Income|AVITA Medical, Inc - Net Profit|Company Net Income Profound Medical Corp.|BDMD: Net Profit|Company Profit EDAP|APYX (Apyx Medical Corp) - Net Profit|IceCure Medical, Ltd. (ICCM) - Net Financial Result|Net Profit LUNG|Net Income telabio.com TELA|Net Profit CTSO (CytoSorbents Corporation)|Net Profit sensushealthcare.com SRTS|ZYXI - Company Net Income|ECOR: Company Net Income|RBOT (vicarioussurgical.com) - Net Income|Inspira Technologies - Final Profit|ICU (SeaStar Medical Holding) - Net Profit|Company Net Income IRIDEX Corp. IRIX|Company Net Income Intelligent Bio Solutions (INBS)|beyondair.net (XAIR) - Annual Net Income|Profusa, Inc. - Net Income|Net Profit STRATA Skin Sciences Inc. SSKN|GlucoTrack - Net Profit|Net Financial Result NanoVibronix Inc. NAOV|Venus Concept (VERO) - Company Net Income|Profit After Tax NUWE (Nuwellis Inc)|Company Net Income Aethlon|Net Income TransEnterix (ASXC)|Net Profit AVGR|BSGM - Company Net Income|Company Net Income Cutera CUTR|KNW: Company Profit|NARI: Net Income|Nevro Medical - Profit After Payment of Taxes|RSLS: Net Profit|Net Income silkroadmed.com